Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance
AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY24 adjusted EPS loss of $(0.12), beating the consensus of $(0.13) but higher than $(0.06) reported a year ago.</